Management of Hyperglycemia in In-hospital COVID-19 Patients: A Review

JOURNAL TITLE: Bengal Physician Journal

Author
1. Santanu K Tripathi
2. Shambo S Samajdar
3. Shashank R Joshi
4. Shreyashi Dasgupta
ISSN
DOI
10.5005/jp-journals-10070-7027
Volume
7
Issue
2
Publishing Year
2020
Pages
4
Author Affiliations
    1. Department of Clinical Pharmacology, Diabetes & Allergy-Asthma Therapeutics Specialty Clinic, Kolkata, West Bengal, India
    1. Department of Clinical Pharmacology, School of Tropical Medicine, Kolkata, West Bengal, India
    1. Department of Pharmacology, Netaji Subhash Medical College and Hospital, Patna, Bihar, India
    1. Department of Endocrinology, Joshi Clinic, Mumbai, Maharashtra, India
  • Article keywords
    COVID-19, Diabetes, Hypoglycemia, Insulin

    Abstract

    The current coronavirus-19 (COVID-19) pandemic has diverted the world\'s attention to the burning problem of infectious diseases and their management. Clinicians are increasingly realizing that the management of diseases like COVID-19 requires not only antimicrobial drugs but also drugs or strategies to tackle the various comorbidities occurring or aggravating due to the disease. Hypoglycemia is one of the important adverse effects of hydroxychloroquine, used frequently in COVID-19. The known diabetics affected with COVID-19 are therefore at a greater risk of hypoglycemia. In this review article, we describe the management strategy for the known diabetics infected with COVID-19 and admitted in inpatient settings, including the dose calculations for insulin infusion and subcutaneous administration of insulin.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved